|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-14 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 2.56M 2.26M 2.14M 1.94M 3.64M 246M 3.67M 25.67M 9.89M 126M 9.62M 9.42M 404M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 24.42M 21.55M 20.39M 18.49M 34.66M 2.34B 35.01M 245M 94.26M 1.2B 91.69M 89.69M 3.85B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.46% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 21/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 16/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 01/04/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 21/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 21/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | +0.48% | +61.83% | +118.89% | 1,056B | |
| -2.00% | -0.98% | +46.76% | +71.13% | 655B | |
| -1.33% | -0.98% | +17.68% | +76.18% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | |
| -0.34% | +1.63% | +52.18% | +55.13% | 226B | |
| -1.61% | -2.01% | +32.84% | +99.63% | 189B | |
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | |
| Average | -0.97% | +0.97% | +28.16% | +48.92% | 404.77B | |
| Weighted average by Cap. | -1.05% | +1.04% | +38.19% | +69.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 25.18M 23.83M 21.61M 40.51M 2.74B 40.91M 286M 110M 1.4B 107M 105M 4.5B | 20.71M 18.28M 17.29M 15.68M 29.4M 1.99B 29.69M 207M 79.96M 1.01B 77.77M 76.08M 3.27B |
| Net income | -39.26M -34.65M -32.78M -29.73M -55.73M -3.77B -56.28M -393M -152M -1.92B -147M -144M -6.19B | -48.06M -42.41M -40.13M -36.39M -68.23M -4.61B -68.9M -481M -186M -2.35B -180M -177M -7.58B |
| Net Debt | 6.05M 5.34M 5.05M 4.58M 8.59M 581M 8.67M 60.6M 23.36M 296M 22.72M 22.22M 954M | 21.85M 19.29M 18.25M 16.55M 31.03M 2.1B 31.33M 219M 84.37M 1.07B 82.06M 80.28M 3.45B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
